These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22689059)

  • 1. Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis.
    Akbay EA; Peña CG; Ruder D; Michel JA; Nakada Y; Pathak S; Multani AS; Chang S; Castrillon DH
    Oncogene; 2013 Apr; 32(17):2211-9. PubMed ID: 22689059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of telomere attrition in type I and II endometrial carcinogenesis.
    Akbay EA; Contreras CM; Perera SA; Sullivan JP; Broaddus RR; Schorge JO; Ashfaq R; Saboorian H; Wong KK; Castrillon DH
    Am J Pathol; 2008 Aug; 173(2):536-44. PubMed ID: 18599611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.
    Suryo Rahmanto Y; Shen W; Shi X; Chen X; Yu Y; Yu ZC; Miyamoto T; Lee MH; Singh V; Asaka R; Shimberg G; Vitolo MI; Martin SS; Wirtz D; Drapkin R; Xuan J; Wang TL; Shih IM
    Nat Commun; 2020 Jun; 11(1):2717. PubMed ID: 32483112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of telomeres 1 proteins POT1a and POT1b can repress ATR signaling by RPA exclusion, but binding to CST limits ATR repression by POT1b.
    Kratz K; de Lange T
    J Biol Chem; 2018 Sep; 293(37):14384-14392. PubMed ID: 30082315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct telomere length regulation in premalignant cervical and endometrial lesions: implications for the roles of telomeres in uterine carcinogenesis.
    Maida Y; Kyo S; Forsyth NR; Takakura M; Sakaguchi J; Mizumoto Y; Hashimoto M; Nakamura M; Nakao S; Inoue M
    J Pathol; 2006 Oct; 210(2):214-23. PubMed ID: 16909412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.
    Hockemeyer D; Daniels JP; Takai H; de Lange T
    Cell; 2006 Jul; 126(1):63-77. PubMed ID: 16839877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas.
    Feng YZ; Shiozawa T; Horiuchi A; Shih HC; Miyamoto T; Kashima H; Suzuki A; Nikaido T; Konishi I
    Virchows Arch; 2005 Nov; 447(5):816-22. PubMed ID: 16021509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.
    Vilgelm A; Lian Z; Wang H; Beauparlant SL; Klein-Szanto A; Ellenson LH; Di Cristofano A
    Cancer Res; 2006 Apr; 66(7):3375-80. PubMed ID: 16585156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
    Sherman ME; Bur ME; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1268-74. PubMed ID: 7590703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed model for endometrial serous carcinogenesis.
    Zheng W; Xiang L; Fadare O; Kong B
    Am J Surg Pathol; 2011 Jan; 35(1):e1-e14. PubMed ID: 21164282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No overt nucleosome eviction at deprotected telomeres.
    Wu P; de Lange T
    Mol Cell Biol; 2008 Sep; 28(18):5724-35. PubMed ID: 18625717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres.
    Wu L; Multani AS; He H; Cosme-Blanco W; Deng Y; Deng JM; Bachilo O; Pathak S; Tahara H; Bailey SM; Deng Y; Behringer RR; Chang S
    Cell; 2006 Jul; 126(1):49-62. PubMed ID: 16839876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination.
    He H; Multani AS; Cosme-Blanco W; Tahara H; Ma J; Pathak S; Deng Y; Chang S
    EMBO J; 2006 Nov; 25(21):5180-90. PubMed ID: 17053789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
    Ambros RA; Sherman ME; Zahn CM; Bitterman P; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.